18F-FDG PET/CT and sentinel lymph node biopsy in the staging of patients with cervical and endometrial cancer. Role of dual-time-point imaging

Rev Esp Med Nucl Imagen Mol. 2017 Jan-Feb;36(1):20-26. doi: 10.1016/j.remn.2016.07.003. Epub 2016 Sep 22.
[Article in English, Spanish]

Abstract

Objective: Definitive staging for cervical (CC) and endometrial cancer (EC) takes place once surgery is performed. The aim of this study was to evaluate the role of PET/CT in detecting lymphatic metastasis in patients with CC and EC using dual-time-point imaging (DPI), taking the histopathological results of sentinel lymph node (SLN) and lymphadenectomy as the reference.

Material and methods: A prospective study was conducted on 17 patients with early CC, and 13 patients with high-risk EC. The patients had a pre-operative PET/CT, MRI, SLN detection, and lymphadenectomy, when indicated. PET/CT findings were compared with histopathological results.

Results: In the pathology study, 4 patients with CC and 4 patients with EC had lymphatic metastasis. PET/CT showed hypermetabolic nodes in 1 patient with CC, and 5 with EC. Four of these had metastasis, one detected in the SLN biopsy. Four patients who had negative PET/CT had micrometastasis in the SLN biopsy, 1 patient with additional lymph nodes involvement. The overall patient-based sensitivity, specificity, positive and negative predictive values, and accuracy of PET/CT to detect lymphatic metastasis was 20.0%, 100.0%, 100.0%, 87.9%, and 88.2%, respectively, in CC, and 57.1%, 88.9%, 66.7%, 84.2% and 80.0%, respectively, in EC. DPI showed higher retention index in malignant than in inflammatory nodes, although no statistically significant differences were found.

Conclusions: PET/CT has low sensitivity in lymph node staging of CC and EC, owing to the lack of detection of micrometastasis. Thus, PET/CT cannot replace SLN biopsy. Although no statistically significant differences were found, DPI may help to differentiate between inflammatory and malignant nodes.

Keywords: Cervical cancer; Cáncer de cérvix; Cáncer de endometrio; Dual-time-point imaging; Endometrial cancer; Ganglio centinela; Imagen dual-time-point; PET/CT; PET/TC; Sentinel lymph node.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Carcinoma / diagnostic imaging
  • Carcinoma / pathology
  • Carcinoma / secondary*
  • Endometrial Neoplasms / diagnostic imaging*
  • Endometrial Neoplasms / pathology
  • Female
  • Fluorine Radioisotopes
  • Fluorodeoxyglucose F18
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision
  • Lymphatic Metastasis / diagnostic imaging*
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neoplasm Staging / methods*
  • Positron Emission Tomography Computed Tomography / methods*
  • Prospective Studies
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Sentinel Lymph Node / diagnostic imaging*
  • Sentinel Lymph Node Biopsy
  • Uterine Cervical Neoplasms / diagnostic imaging*
  • Uterine Cervical Neoplasms / pathology

Substances

  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Fluorine-18